Depleting Egr in hemocytes led to a decrease in tumor size and a mitigation of tumor size sex difference, while Egr knockdown in the fat body with either R4-Gal4 or Lpp-Gal4 had no significant effect on tumor growth (Fig. 3G). The gene discussed is CD1A; the disease is neoplasm.